By
Drug Target Review2025-01-24T08:00:01
UVA researchers found that continuous glucose monitor data can predict nerve, eye, and kidney damage in type 1 diabetes.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-10T06:15:00Z
Contributor Professor Donald E Ingber, By Drug Target Review
2026-07-08T12:00:00Z
2026-07-01T13:30:00
Contributor Carrie Maynard and Dr Veronica Fowler
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2026-05-12T09:31:00
Contributor Sugish Pillai, Axel Ziemke and Dr Gary Kusdian
2026-05-26T09:05:00
Contributor Thomas Clozel M.D., By Drug Target Review
2026-07-10T06:15:00
Contributor Professor Donald E Ingber, By Drug Target Review
2026-06-30T14:00:00
Sponsored by Analytik Jena GmbH + Co. KG
Site powered by Webvision Cloud